Interphase cytogenetic analysis of chromosome 13q14 was performed in 28 patients with multiple myeloma (MM) receiving high-dose therapy followed by autologous (n=24) or allogeneic (n=4) stem cell support. Eleven (39%) patients were found to have a deletion of chromosome 13q14. Response rates to high-dose therapy were independent of the chromosome 13 status, but patients with a deletion of 13q14 had a significantly shorter progression-free (p=0.001) and overall survival (p=0.012) than patients with normal chromosome 13q14. Our results indicate that high-dose therapy appears promising in patients with normal chromosome 13, whereas in patients with a deletion of 13q14 innovative therapeutic concepts are warranted.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s002770100296 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Loss of chromosome cytoband 13q14.2 orchestrates breast cancer pathogenesis and drug response.
Breast Cancer Res
November 2024
Department of Medical Genetics, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo and Oslo University Hospital, Oslo, Norway.
Article Synopsis
- - Breast cancer (BCa) presents a significant health challenge worldwide, with many tumors showing extensive genetic alterations known as somatic copy number alterations (CNAs) that influence tumor behavior and patient outcomes.
- - Loss of the chromosome segment 13q14.2 is a common and important CNA found in up to 63% of BCa patients, associated with poorer survival rates, and its impact is complex, enhancing both cancer cell growth and immune responses in the tumor environment.
- - This loss of 13q14.2 also increases the effectiveness of BCL2 inhibitors in treating BCa, suggesting it could be used as a biomarker to help predict patient prognosis and guide treatment options.
Prenatal diagnosis and genetic analysis: rare familial chromosomal duplications larger than 5 Mb without disease phenotypes.
Pediatr Res
November 2024
Department of Obstetrics & Gynecology, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, China.
Article Synopsis
- The study aimed to identify harmless large chromosomal duplications (>5 Mb) through long-term clinical follow-ups of affected fetuses and their families.
- Researchers analyzed fetuses with these duplications, conducting genetic tests and phenotype assessments, discovering eight cases where duplications ranged from 5.3 to 12.2 Mb across various chromosomes.
- The findings concluded that all carriers were asymptomatic, providing useful data for genetic counseling regarding these large duplications that have been passed through generations without causing any noticeable health issues.
Genetic disorders and their association with morbidity and mortality in early preterm small for gestational age infants.
Am J Obstet Gynecol
September 2024
Division of Neonatology, Department of Pediatrics, Columbia University Irving Medical Center, New York City, NY. Electronic address:
Article Synopsis
- The study focuses on early preterm infants who are small for gestational age (SGA) and examines the role of genetic disorders in their high rates of morbidity and mortality.
- Researchers conducted a retrospective analysis of infants born between 2000-2020, comparing the prevalence of genetic disorders in SGA infants (with and without congenital anomalies) to those who were appropriate for gestational age (AGA).
- Findings revealed that genetic disorders were identified in a small percentage of SGA infants, with trisomies 13, 18, and 21 being the most common, highlighting the need for further research on genetic factors contributing to their health outcomes.
Comparison of Three FISH Probes Used By FISH Test For 13q Deletion in Chronic Lymphoid Leukemia.
J Assoc Genet Technol
January 2024
Cytogenetics Lab director, Department of Pathology, Moffitt Cancer Center, Tampa, FL.
Fluorescence in situ hybridization (FISH) is a reliable method to detect a deletion on chromosome 13q14. Currently, three commercial probes are available for FISH testing in clinical cytogenetics laboratories, RB1, D13S319, and D13S25, with the D13S319 probe most commonly used for 13q deletion. In this study, we compared FISH test results among these three probes in CLL cases with positive 13q deletion.
View Article and Find Full Text PDFObesity as a Confounding Factor in the Diagnosis of Wilson's Disease: Case Report of Two Siblings with the Same Genotype but Different Clinical Courses.
Curr Issues Mol Biol
June 2024
Hepatology Unit, Department of Clinical and Experimental Medicine, Policlinico "G. Rodolico-San Marco" Hospital, University of Catania, 95123 Catania, Italy.
Wilson's disease (WD) is a biallelic disease-causing variant in the gene on chromosome 13q14.3 that results in copper accumulation in many organs, particularly the liver and brain. The phenotypic spectrum is wide and symptoms at onset can be heterogeneous.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!